Last week, the world woke to the news that a new, highly transmissible coronavirus variant – dubbed “omicron” – had been identified by researchers in South Africa. The number of new infections has since risen from the hundreds to the thousands in the country, where residents are mostly unvaccinated.
The news prompted many countries to close their borders or restrict travel from southern Africa, and the World Health Organization classified omicron a “variant of concern.”
“Omicron, B.1.1.529, is named as a variant of concern because it has some concerning properties,” said Maria Van Kerkhove, an infectious diseases epidemiologist with the organization. “This variant has a large number of mutations, and some of these mutations have some worrying characteristics.”
Researchers around the world are trying to learn as much as they can about omicron. UVA Today reached out with questions to infectious diseases expert Dr. Bill Petri, who recently was awarded the Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases.
Q. Can you describe the new variant and its virulence?
A. The omicron variant had never been seen until this month, and it was first identified in early November in South Africa. And what has captured everyone’s attention is that in South Africa, at least, it’s more infectious than is [the] delta [variant].

